Obalon Completes Enrollment For U.S. Pivotal Trial of Novel Weight Loss Balloon
June 2, 2015Obalon completed patient enrollment in a multi-center U.S. pivotal trial of the Obalon balloon, their novel weight loss device, and expects the data from the trial necessary to file for approval with the FDA by the end of 2015.
More »
Xagenic Fuels Platform Expansion Strategy with Exclusive Technology Acquisition
June 1, 2015Xagenic acquired the rights to University of Toronto's mutation detection technology that detects cfNA in blood, potentially enabling its X1 platform to expand into "liquid biopsy."
More »
Dicerna Presents Preliminary Safety and Efficacy Data from DCR-MYC Phase 1 Study at ASCO 2015
June 1, 2015The interim data provide evidence of clinical and metabolic response in patients across several dose levels. Evidence of clinical anti-tumor activity was observed in two patients with advanced, treatment refractory pancreatic neuroendocrine tumors (PNETs)
More »